share_log

Glimpse Group Analyst Ratings

Benzinga ·  Aug 22, 2023 08:43
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/22/2023 199.66% WestPark Capital → $8.87 Initiates Coverage On → Buy
06/05/2023 136.49% EF Hutton → $7 Reiterates → Buy
05/17/2023 136.49% EF Hutton → $7 Reiterates Buy → Buy
02/16/2023 136.49% EF Hutton → $7 Reiterates → Buy
12/19/2022 136.49% EF Hutton → $7 Assumes → Buy
06/13/2022 305.41% EF Hutton $14 → $12 Maintains Buy
01/24/2022 372.97% EF Hutton → $14 Initiates Coverage On → Buy

What is the target price for Glimpse Group (VRAR)?

The latest price target for Glimpse Group (NASDAQ: VRAR) was reported by WestPark Capital on August 22, 2023. The analyst firm set a price target for $8.87 expecting VRAR to rise to within 12 months (a possible 199.66% upside). 5 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Glimpse Group (VRAR)?

The latest analyst rating for Glimpse Group (NASDAQ: VRAR) was provided by WestPark Capital, and Glimpse Group initiated their buy rating.

When is the next analyst rating going to be posted or updated for Glimpse Group (VRAR)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Glimpse Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Glimpse Group was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.

Is the Analyst Rating Glimpse Group (VRAR) correct?

While ratings are subjective and will change, the latest Glimpse Group (VRAR) rating was a initiated with a price target of $0.00 to $8.87. The current price Glimpse Group (VRAR) is trading at is $2.96, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment